Antibacterial and Antioxidant Properties of the Methanolic Extract of the Stem Bark of Pteleopsis hylodendron (Combretaceae) by Mokale Kognou, Aristide Laurel et al.
Hindawi Publishing Corporation
ChemotherapyResearch and Practice
Volume 2011, Article ID 218750, 7 pages
doi:10.1155/2011/218750
Research Article
Antibacterialand AntioxidantProperties
oftheMethanolic ExtractoftheStemBarkof
Pteleopsishylodendron (Combretaceae)
AristideLaurelMokaleKognou,1 RosalieAnnie NgonoNgane,2 JulesRogerKuiate,1
MartinLutherKoanga Mogtomo,2 AlembertTchindaTiabou,3
RaymondSimplice Mouokeu,1 LucieBiyiti,4 and PaulHenri Amvam Zollo4
1Laboratory of Microbiology and Antimicrobial Substances, University of Dschang, P.O. Box 67 Dschang, Cameroon
2Department of Biochemistry, University of Douala, P.O. Box 24157 Douala, Cameroon
3Laboratory of Phytochemistry, Institute of Medical Research and Medicinal Plants Study,
Ministry of Scientiﬁc Research and Innovation, P.O. Box 6163, Yaound´ e, Cameroon
4Department of Biochemistry, University of Yaound´ eI ,P . O .B o x8 1 2Y a o u n d ´ e, Cameroon
Correspondence should be addressed to Rosalie Annie Ngono Ngane, angono@yahoo.com
Received 27 October 2010; Accepted 17 January 2011
Academic Editor: AthanassiosTsakris
Copyright © 2011 Aristide Laurel Mokale Kognou et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Pteleopsis hylodendron (Combretaceae) is used in Cameroon and West Africa folk medicine for the treatment of various microbial
infections (measles, chickenpox, and sexually transmitted diseases). The antibacterial properties of the methanolic extract and
f r a c t i o n sf r o ms t e mb a r ko fPteleopsis hylodendron were tested against three Gram-positive bacteria and eight Gram-negative
bacteria usingAgar-well diﬀusion and Broth microdilution methods. Antioxidant activities of the crude extract and fractions were
investigated by DPPH radical scavenging activity and β-carotene-linoleic acid assays. The methanolic extract and some fractions
exhibited antibacterial activities that varied between the bacterial species (ID = 0.00–25.00mm; MIC = 781–12500μg/mL and
0.24–1000μg/mL). The activity of the crude extract is, however, very weak compared to the reference antibiotics (MIC = 0.125–
128μg/mL). Two fractions (FE and FF) showed signiﬁcant activity (MIC = 0.97μg/mL) while S. aureus ATCC 25922 was almost
resistant to all the tested fractions. In addition, the crude extract and some fractions showed good antioxidant potential with
inhibition values ranging from 17.53 to 98.79%. These results provide promisingbaseline informationfor the potential use of this
plant as well as some of the fractions in the treatment of infectious diseases and oxidative stress.
1.Introduction
Since the successive introduction of various antibiotics into
therapeutics, the sensitivity of pathogenic microorganisms
changedalotsothattheproportionofantibioticallyresistant
strains is currently important [1], what involves an increase
in seriousness of infectious diseases as gastroenteritis (GE)
which are a problem of public health on a worldwide scale
but especially in Africa [2]. Diarrhea, its main characteristic
is a major cause of morbidity and mortality among children
in developing countries. According to the World Health
Organization (WHO), there are more than 2 million deaths
per year [3]. Moreover, therapy with synthetic antibiotics
is not always possible because of their high cost as well as
toxicityduetotheirextendeduse.To overcomethisproblem,
people in developing countries use preparations obtained
from plants following folk tradition for their primary health
care because of low cost with little or no undesirable side
eﬀects [4]. The plants represent a potential and almost
inexhaustible source of new anti-infective compounds [5]
and many of them are used to treat GE eﬀectively [6].
Pteleopsis hylodendron Mildbr. belongs to the family
Combretaceae commonly found in the forest regions of West
and Central Africa. The genus Pteleopsis is represented in2 Chemotherapy Research and Practice
Africa by ten species but only P. hylodendron is found in
Cameroon [7]. The aqueous decoction of the stem bark
of P. hylodendron is used to treat measles, chickenpox,
sexually transmitted diseases, GE, female sterility, liver and
kidney disorders, as well as dropsy [8]. Phytochemical,
antimicrobial, toxicity and antioxidant works have been
previously reported of this plant [9, 10]. In the same logic,
we have analysed the stem bark of Pteleopsis hylodendron and
report here the antibacterial activity on pathogenic bacteria
of the gastro-intestinal tract and antioxidant activity of the
crude extract and fractions.
2.MaterialandMethods
2.1. Plant Material. The stem bark of P. hylodendron was
collected in February 2009 at Mbeyengue I, Centre region of
Cameroon. Identiﬁcation was done at the National Herbar-
ium in Yaound´ e, Cameroon, where a voucher specimen (No
1309/SFRK)has been deposited.
2.2. Microorganisms. Five bacterial strains and six isolates
known to be pathogenic of the gastro-intestinal tract were
used in this work. These included three Gram+ bacteria
(Enterococcus faecalis ATCC 10541, Staphylococcus aureus
ATCC 25922 and Staphylococcus aureus)a n de i g h tG r a m −
bacteria (Escherichia coli ATCC 11775, Escherichia coli,
Proteus mirabilis, Pseudomonas aeruginosa ATCC 27853,
Salmonella paratyphi A, Salmonella paratyphi B, Salmonella
typhi ATCC 6539, and Shigella ﬂexeneri). The bacterial
isolates were obtained from Centre Pasteur of Yaound´ e,
Cameroon, while the reference strains were obtained from
American Type Culture Collection (ATCC). The bacterial
strains and isolates were grown at 35◦C and maintained on
nutrient agar. The bacterial cell suspension was prepared at
1.5 × 108 colony forming units per mL (CFU/mL) following
the McFarland 0.5 turbidity standard.
2.3. Extraction and Fractionation. The air-dried and pow-
dered stem bark of Pteleopsis hylodendron (2.5kg) was
extracted with MeOH (8L, 72h) at room temperature
to obtain a crude extract (590g) after evaporation under
vacuum. A portion of this extract (100g) was subjected
to silica gel column chromatography (Ø8cm × L30cm)
elutedsuccessivelywith purehexane, hexane-EtOAc(90:10–
30:70), pure EtOAc, EtOAc-MeOH (95:5–80:20) and pure
MeOH.Forty-sixfractionsof500mLeachwerecollectedand
combinedbasedontheirTLC proﬁleintotenmajor fractions
A–J(A: 2-3, B: 4–6, C: 7–13, D: 14–16,E: 17–21, F: 22–28, G:
29–35, H: 36-37, I: 38–44, J: 45–46).
2.4. Antibacterial Assays
2.4.1. Agar-Well Diﬀusion Method. Diameters of inhibition
zones (ID) were determined using Mueller Hinton Agar
(MHA) by the well diﬀusion method [11]. The bacterial
suspension (100μL) was homogeneously seeded onto Petri
dishes containing sterile molten MHA (20mL). The sterile
6mm diameter wells were impregnated (50μL) with dif-
ferent concentrations of plant extract (10, 5, and 2.5mg–
200, 100, and 50μg / m L ) .T h ed i s h e sw e r ek e p tf o r1 ha t
room temperature for the diﬀusion of the extract. Subse-
quently, dishes were incubated at 35◦C for 24h. Antibiotics
(Amoxicillin, Ciproﬂoxacin and Gentamicin) were used as
positivecontrol(10μg–200μg/mL)and10%aqueousDMSO
was used as negative control. Results were evaluated by
measuring the inhibition zones around each well. The assay
w a sd o n ei nt r i p l i c a t ea n dt h em e a nd i a m e t e r sr e c o r d e da s
inhibition zones. We considered that an extract is active
when ID was up to 20mm, and then the strain is known
as sensitive; moderately active when ID was between 10 and
20mm, and then the strain is known as moderate; little or
not active when ID was between 0 and 10mm, and then the
strain is known as little sensitive or resistant [12, 13].
2.4.2. Broth Microdilution Method. Minimum inhibitory
concentrations (MICs) were determined using Mueller Hin-
ton Broth (MHB) by microdilution method [14]. A two-
fold serial dilutionofthe crudeextract (12.50–0.024mg/mL)
and fractions (1000–1.953μg/mL and 500–0.242μg/mL).
A negative control (10%, v/v aqueous DMSO, medium
and inoculum) and positive control (10%, v/v aqueous
DMSO, medium, inoculum and water-soluble antibiotics)
were included. Each well of 96-well sterile microtitre plate
received 100μL of MHB, 100μLo ft e s ts u b s t a n c e sa n d
100μL of the bacterial inoculum (1.5 × 108 CFU/mL). The
plates were covered and incubated at 35◦Cf o r2 4 h .A sa n
indicator of bacterial growth, 50μL p-iodonitrotetrazolium
violet (INT) dissolved in water was added to the wells and
incubated at 35◦C for 30min. MIC values are recorded as
the lowest concentration of the substance that completely
inhibited bacterial growth that is, the solution in the
well remained clear after incubation with INT. Minimum
bactericidal concentrations (MBCs) were determined by
plating 10μL from each negative well and from the positive
g r o w t hc o n t r o lo nM u e l l e rH i n t o nA g a r .M B C sw e r ed e ﬁ n e d
as the lowest concentration yielding negative subcultures.
The experiments were performed in triplicate. Amoxicillin,
ciproﬂoxacin and gentamicin at the concentration ranging
between 128 and 0.062μg/mL served as positive control.
2.5. Antioxidant Assay
2.5.1.DPPHAssay. Thefreeradicalscavengingactivityofthe
extract and fractions on the stable radical DPPH were
estimated by the method of Mensor et al. [15]. 1.5mL of a
methanol solution of sample test at diﬀerent concentrations
(10, 50, 100, 500, and 1000μg/mL) was mixed with a 0.3mM
DPPH methanol solution and kept for 30min at room
temperature. The decrease in the solution absorbance, due
to proton donating of substances was measured at 517nm.
L-Ascorbic acid was used as positive control. The percentage
of DPPH radical scavenging activity was calculated using the
following formula:
DPPH radical scavenging activity (%)
=
⎡
⎣
 
Acontrol −Asample test
 
Acontrol
⎤
⎦ × 100.
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2.5.2. β-Carotene-Linoleic Acid Assay. In this assay antioxi-
dant capacity is determined by measuring the inhibition of
the volatile organic compounds and the conjugated diene
hydroperoxides arising from linoleic acid oxidation [16].
A stock solution of β-carotene-linoleic acid mixture was
prepared as follows: 1.5mg β-carotene was dissolved in 3mL
of chloroform, and 75μL linoleic acid and 600mg tween 40
were added. Chloroform was completely evaporated using a
vacuum evaporator. Then 150mL distilled water saturated
with oxygen was added with a vigorous shaking. 1340μLo f
this reaction mixture was dispersed to test tubes and 160μL
extract (20mg/mL) were added, and emulsion system was
incubatedat 55◦Cfor105min. Same procedurewas repeated
with L-Ascorbic acid used as a standard control and a blank.
Afterthis incubationperiod absorbance ofthe mixtures were
measured at 492nm. Antioxidative capacity of the extract
was compared with those of ascorbic acid and blank.
2.6. Phytochemical Screening. Chemical tests were carried
out on the methanolic extract and fractions using standard
procedures to identify the constituents (alkaloids, antho-
cyanins, anthraquinones, coumarins, ﬂavonoids, glycosides,
phenols, polyphenols, saponins, tannins, triterpenes, and
sterols) as described by Brunetton [17].
2.7. Statistical Analysis. Data were expressed as mean ±
standard deviation. Statistical analysis was carried out using
the Waller-Duncan’s test. The 12.0 SPSS Windows software
was used for this analysis. Diﬀerences were considered
signiﬁcant at P<. 05.
3.Results
3.1.Extractionand Fractionation. The % yield of methanolic
extract of P. hylodendron was 15.96%. FI (43.08%) and FJ
(24.54%) were the most abundant.
3.2. Phytochemical Screening. Phytochemical screening re-
vealed the presence of medicinally active constituents. The
diﬀerences in the composition between crude extract and
fractions and between fractions were noted. Except FA,a l l
othersubstancescontainedatleastonechemicalgroup.Alka-
loids, anthocyanins, anthraquinones, ﬂavonoids, glycosides,
phenols, polyphenols, saponins, and tannins were present in
crude extract while coumarins, sterols, and triterpenes were
absent. FB,F C,a n dF D had a similar chemical composition
(alkaloids). It is the same for FG and FH (alkaloids, antho-
cyanins, anthraquinones, ﬂavonoids, phenols, polyphenols,
and tannins); FI and FJ (ﬂavonoids, glycosides, phenols,
polyphenols, saponins, and tannins).
3.3. Antibacterial Activity. The results of the antibacterial
activity by the Agar-well diﬀusion method are presented
in Table 1. At the three concentrations of the methanolic
extract tested, ID ranged from 0.00 to 25.00mm for all
the bacteria 15.00–25.00mm for the isolates 0.00–22.00mm
for the Gram−, and 10.87–25.00mm for the Gram+. S.
aureus was the most sensitive (ID = 20.00–25.00mm) while
S. aureus ATCC 25922 and E. coli ATCC 11775 were the least
sensitive (ID = 11.00–15.00mm and 10.00–14.75mm resp.).
No activity was recorded at 2.5mg against P. aeruginosa
ATCC 27853. However these values are weak compared with
those of the reference antibiotics (ID = 12–40mm).
In view ofthe results obtained by diﬀusionmethod, MIC
and MBC values of the crude extract and fractions were
established and the results are shown in Tables 2 and 3.
All the bacteria tested were inhibited by the methanolic
extract (Table 2) with MIC ranging from 781–12500μg/mL
for all the bacteria, isolates, and Gram−; 781–3125μg/mL
for the strains and Gram+. S. paratyphi Aw a st h el e a s t
sensitive (MIC = 12500μg/mL). P. aeruginosa ATCC 27853,
P. mirabilis and S. aureus were the most sensitive (MIC =
781μg/mL). The important activity on S. aureus conﬁrms
the best activity obtained in solid medium; which revealed
this germ as one of the most susceptible. Antibiotics exerted
a higher inhibitory eﬀect on bacterial (MIC = 0.125–
128μg/mL) than the methanolic extract.
The fractionation of the methanolic extract showed an
inactivity of FA,F B,F C,a n dF D on all the bacteria tested
(Table 3). On the contrary, FE and FF saw their activity
increasing signiﬁcantly. Indeed, on ﬁve of the eleven bacteria
(E. coli, P. mirabilis, S. paratyphi B, E. faecalis ATCC10541, S.
aureus), MIC was 0.97μg/mL, making the substances more
active than reference antibiotics. FG had a fairly good activity
(MIC = 0.24μg/mL) on some bacteria (P. aeruginosa ATCC
27853, E. faecalis ATCC 10541, S. aureus)w h e r e a sF H,F I
and FJ were slightly active (MIC = 125–1000μg/mL). S.
aureus ATCC 25922 was almost resistant to all the fractions
(MIC > 1000μg/mL). The MBC/MIC ratio activity for all
the bacteria tested varied between one (1) and eight (8) for
the crude extract and between one (1) and twenty (20) for
the fractions. According to Marmonier [18], plant extract
and fractions exerted two types of activities: a bacteriostatic
(MBC/MIC ≥ 4) and bactericidal activity (MBC/MIC ≤
4). Methanolic extract and fractions of P. hylodendron were
bactericidal on at least 63% and 27% of the bacteria
respectively.
3.4. Antioxidant Activity. The antioxidant activity of the
methanolic extract and fractions was assessed by the DPPH
and β-carotene-linoleic acid assays. The results are presented
in Tables 4 and 5. Activity increased in a concentration-
dependant manner compared to L-ascorbic acid (positive
antioxidant control). At the concentrations of 500 and
1000μg/mL the methanolic extract, FE,F F,F G,F H,F I,a n d
FJ showed a similar activity to that one of L-ascorbic acid.
FH was the most antioxidant fraction (94.05–98.79%) while
FA was the least antioxidant (1.86–21.26%).
4.Discussionand Conclusion
Phytochemical screening of the methanolic extract and
fractions of P. hylodendron revealed the presence alkaloids,
anthocyanins, anthraquinones, ﬂavonoids, glycosides, phe-
nols, polyphenols, saponins and tannins. Other investigators
[19, 20] have reported the presence of these components in4 Chemotherapy Research and Practice
Table 1: ID (mm) of the methanolic extract of P. hylodendron.
Bacteria
Crude extract (mg/mL) Reference antibiotic (μg/mL)
P. hylodendron Amoxicillin Ciproﬂoxacin Gentamicin
200 100 50 200
Gram− bacteria
E. coli ATCC 11775 14.75 ±0.17
f 12.25 ± 0.17
h 10.00 ± 0.00
g 19.00 ±0.26
d 28.25 ±0.17
f 27.00 ±0.26
f
E. coli 21.75 ±0.13b 19.00 ±0.00c 16.75 ± 0.17c 40.00 ±0.00a 27.75 ±0.17f 26.00 ±0.00h
P. aeruginosa ATCC 27853 18.62± 0.27d 13.75 ± 0.17f 0.00 ± 0.00h 14.50 ± 0.42g 32.50 ± 0.17d 30.00 ± 0.00d
P. mirabilis 20.12 ±0.12c 18.00± 0.00d 16.00 ±0.00d 16.00 ± 0.00f 33.00 ±0.00c 33.25 ±0.17a
S. ﬂexneri 21.75 ±0.17
b 19.75 ±0.17
b 17.50 ±0.18
b 20.00 ± 0.00
c 36.50 ±0.42
a 32.00 ±0.00
b
S. paratyphi A2 0 .25 ±0.17
c 17.00 ±0.00
e 15.00 ±0.00
e 12.00 ± 0.00
h 30.00 ±0.00
e 28.00 ±0.00
c
S. paratyphi B1 9 .75 ±0.17c 17.62± 0.12d 15.12 ±0.12e 14.25 ± 0.17g 35.00 ±0.00b 28.25 ±0.17e
S. typhi ATCC 6539 22.00 ±0.00b 20.00 ±0.00b 16.87 ± 0.12c 12.00 ± 0.00h 32.33 ± 0.25d 32.00 ±0.00b
Gram+ bacteria
E. faecalis ATCC 10541 16.00 ±0.00
e 13.25 ± 0.17
g 10.87 ± 0.12
f 18.00 ±0.00
e 32.00 ± 0.00
d 31.00 ±0.00
c
S. aureus ATCC 25922 15.00 ±0.00f 13.75 ± 0.17f 11.00 ± 0.00f 20.75 ± 0.17c 35.50 ±0.18c 30.25 ±0.17cd
S. aureus 25.00 ±0.00a 22.00 ±0.00a 20.00 ±0.00a 35.00 ±0.00b 26.00 ± 0.00h 26.75 ±0.24fh
a,b,c,d,e,f,g,hI nt h es a m ec o l u m n ,v a l u e sc a r r y i n gd i ﬀerent letters in superscript are signiﬁcantly diﬀerent at P ≤ .05 (Waller Duncan test).
Diameters of inhibition zones (ID).
Table 2: MIC and MBC (μg/mL) of the methanolic extract of P. hylodendron.
Crude extract Reference antibiotics
Bacteria P. hylodendron Amoxicillin Ciproﬂoxacin Gentamicin
MIC MBC MBC/MIC MIC MBC MBC/MIC MIC MBC MBC/MIC MIC MBC MBC/MIC
Gram− bacteria
E. coli ATCC 11775 3125 12500 4 128 — — 4 4 1 16 128 8
E. coli 1562 — — 1 1 1 8 8 1 1 1 1
P. aeruginosa ATCC 27853 781 781 1 128 — — 1 16 16 8 16 2
P. mirabilis 781 6250 8 1 8 8 1 1 1 2 16 8
S. ﬂexneri 3125 — — 32 64 2 0.25 1 4 0.25 0.25 1
S. paratyphi A 12500 — — — — — 0.125 0.5 4 2 2 1
S. paratyphi B 1562 6250 4 1 8 8 0.5 2 4 2 16 8
S. typhi ATCC 6539 1562 6250 4 — — — 0.25 2 8 32 128 4
Gram+ bacteria
E. faecalis ATCC 10541 1562 6250 4 1 1 1 4 16 4 1 1 1
S. aureus ATCC 25922 3125 6250 2 — — — 8 8 1 4 16 4
S. aureus 781 1562 2 1 — — 8 8 1 0.25 0.25 1
—: 12500μg/mL for the extract and >128μg/mL for the reference antibiotics.
the Combretaceae family to which belongs the studied plant.
However, Ngounou et al. [21] and Atta-Ur-Rahman et al.
[22] working on the stem bark of P. hylodendron collected
from East region of Cameroon revealed the presence of
triterpenes which were absent in our sample. This diﬀerence
canbe attributedtothe diﬀerencein thegeographicalregion,
soil composition, and age of the plant [17].
The antimicrobial activities of Pteleopsis species were
reported [19, 23]. Generally, the methanolic extract and
some fractions of the stem bark of P. hylodendron showed
variableantibacterial activitiesdose-dependantontheeleven
bacterial strains and isolates tested. These broad spectra
of action could be related to their chemical components
[24].Amongthesecompounds,tannins induceanimportant
antimicrobial activity because they have an ability to inacti-
vate microbial adhesions, enzymes, cell envelope transport
proteins, and so forth, [25]. Due to their ability to bind
to proteins and metals, tannins also inhibit the growth of
microorganisms through substrate and metal ion depriva-
tion [26]. However, diﬀerences in chemical composition
recorded between the crude extract and some fractions may
explain their diﬀerent degree of antimicrobial properties.
Also, the amount of the active components in the crude
extract may be diluted and fractionation may have increased
their concentrations, thus the activities in the fractions [27].
Moreover, the diﬀerences in susceptibility may be explained
by the diﬀerences in cell wall composition and/or genetic
content of plasmids that can be easily transferred amongChemotherapy Research and Practice 5
Table 3: MIC and MBC (μg/mL) of the fractions from chromatography separation of P. hylodendron.
Bacteria Parameters Fractions Reference antibiotics
FA FB FC FD FE FF FG FH FI FJ Amox Cipro Genta
Gram− bacteria
E. coli ATCC 11775
MIC — — — — 500 — 62.5 500 1000 1000 128 4 16
M B C ———— — — — — — — — 4 1 2 8
MBC/MIC — — — — — — — — — — — 1 8
E. coli
MIC — — — — 0.97 0.97 62.5 500 1000 1000 1 8 1
M B C ———— — — 2 5 0 — — — 1 8 1
MBC/MIC — — — — — — 4 — — — 1 8 1
P. aeruginosa ATCC 27853
MIC — — — — — — 0.24 1000 1000 1000 128 1 8
M B C ———— — — 2 5 0 — — — — 1 6 1 6
MBC/MIC — — — — — — 20 — — — — 16 2
P. mirabilis
MIC — — — — 0.97 0.97 — 250 500 1000 1 1 2
MBC — — — — 125 62.5 — — — — 8 1 16
MBC/MIC — — — — 14 12 — — — — 8 1 8
S. ﬂexneri
MIC — — — — — — — 250 500 1000 32 0.25 0.25
M B C ———— — — — — — — 6 4 1 0 . 2 5
MBC/MIC — — — — — — — — — — 2 4 1
S. paratyphi A
MIC — — — — — — 500 1000 1000 — — 0.125 2
M B C ———— — — — — — — — 0 . 5 2
MBC/MIC — — — — — — — — — — — 4 1
S. paratyphi B
MIC — — — — 0.97 0.97 500 500 500 1000 1 0.5 2
M B C ———— — — — — — — 8 2 1 6
MBC/MIC — — — — — — — — — — 8 4 8
S. typhi ATCC 6539
MIC — — — — — — 500 1000 — — — 0.25 32
M B C ———— — — — — — — — 2 1 2 8
MBC/MIC — — — — — — — — — — — 8 4
Gram+ bacteria
E. faecalis ATCC 10541
MIC — — — — 0.97 0.97 0.24 500 1000 1000 1 4 1
MBC — — — — 0.97 250 0.24 — — — 1 16 1
MBC/MIC — — — — 1 16 1 — — — 1 4 1
S. aureus ATCC 25922
M I C ———— — — — 5 0 0 — — — 8 4
M B C ———— — — — — — — — 8 1 6
MBC/MIC — — — — — — — — — — — 1 4
S. aureus
MIC — — — — 0.97 0.97 0.24 500 125 250 1 8 0.25
MBC — — — — — — 0.97 — — — — 8 0.25
MBC/MIC — — — — — — 4 — — — — 1 1
F: fraction; Amox: amoxicillin; Cipro: ciproﬂoxacin; Genta: gentamicin.
—: >1000μg/mL for the fractions, and >128μg/mL for the reference antibiotic.
strains [28]. MIC values obtained from the extract by micro-
dilution method revealed that S. aureus is the most sensitive.
It was reported [29]t h a tS. aureus is one of the most
susceptible bacteria to the plant extracts. These values also
showed that the Gram− and Gram+ bacteria had a compara-
ble susceptibility. This may suggest that the mode of action
of the extract was not related to the cell wall composition. S.
aureus ATCC 25922 which was inhibited completely by the
methanolic extract at 3125μg/mL, was almost resistant to all
the fractions. This may suggest that this microbe required
high concentrations of the substance tested and synergic
eﬀect of chemical compounds as extract. FA,F B,F C,a n dF D
containing only alkaloids did not show any inhibitory eﬀect
on the bacteria tested. This may suggest these compounds
which also present in the methanolic extract do not have
a detectable antibacterial activity. However, alkaloids were
reported to possess antibacterial activities [30]. FE and
FF, most active had a comparable chemical composition
that FG.D i ﬀerences in activity between these fractions
could be related to the absence of anthocyanins in FF and6 Chemotherapy Research and Practice
Table 4: Antioxidant potential of the crude extract and fractions of P. hylodendron and L- ascorbic acid in DPPH assay.
% inhibition concentration (μg/mL)
Substances tested 1000 500 100 50 10
FA 21.26 ±0.24f 19.69 ± 0.17i 11.83 ±0.47ef 05.28 ±0.26j 1.86 ±0.17m
FB 22.40 ±0.94f 18.80 ±0.10j 09.19 ± 0.20f 08.83 ±0.34i 04.20 ±0.17l
FC 42.58 ±0.50
e 28.16 ±0.29
h 12.31 ±0.41
e 10.87 ±0.38
h 08.65 ±0.00
k
FD 67.98 ±0.72d 52.13 ±0.10g 20.24 ±0.45d 17.83 ±0.28g 10.81 ±0.37j
FE 95.73 ±0.26bc 94.95 ±0.00d 94.05 ±0.14a 91.77 ±0.33cd 26.30 ±0.20h
FF 95.37 ±0.10bc 94.65 ±0.10d 93.75 ±0.10a 93.33 ±0.14ab 83.42 ± 0.48d
FG 97.83 ±0.37
ab 95.55 ±0.17
c 94.65 ±0.17
a 92.79 ±0.29
bc 91.89 ±0.28
b
FH 98.79 ±0.33
ab 96.21 ±0.13
b 94.47 ±0.26
a 94.29± 0.26
a 94.05 ±0.20
a
FI 95.49 ±0.14bc 94.83 ±0.17d 93.93 ±0.33a 92.67 ±0.38bc 70.08 ±0.64f
FJ 95.85 ±0.00bc 95.13 ±0.14cd 93.57 ±0.30a 93.21 ±0.17ab 74.23 ±0.14e
PH 95.13 ±0.14bc 93.87 ±0.28e 93.39 ±0.10a 91.35 ±0.14d 89.42 ±0.26c
ASC 100.00± 0.00
a 100.00 ±0.00
a 87.36 ±0.00
b 53.23 ±0.00
e 29.42 ±0.00
g
F: fraction; PH: methanolic extract of P. hylodendron;A S C :L - a s c o r b i ca c i d .
a,b,c,d,e,f,g,h,i,j,k,l,mIn the same column, values carrying diﬀerent letters in superscript are signiﬁcantlydiﬀerent at P ≤ .05 (Waller Duncan test).
Table 5: Antioxidant potential of the crude extract of P. hylodendron and L-ascorbic acid in β-carotene-linoleic acid assay.
% inhibition concentration (μg/mL)
Substances tested 1000 500 100 50 10
PH 38.03 ±0.25b 31.83 ±0.16a 31.80 ±0.00a 30.47 ±0.08a 27.73 ±0.08a
ASC 56.48 ±0.05a 27.73 ±0.02b 20.20 ±0.00b 19.86 ±0.00b 17.81 ±0.02b
PH:m e t h a n o l i ce x t r a c to fP. hylodendron;A S C :L - a s c o r b i ca c i d .
a,bIn the same column, values carrying diﬀerent letters in superscript are signiﬁcantly diﬀerent at P ≤ .05 (Waller Duncan test).
anthraquinones in FE. Generally, it is diﬃcult at the sight
of results of the phytochemical screening to attribute the
activities recorded to a chemical compounds group.
As L-ascorbic acid, the methanolic extract and some
fractions showed great antioxidant potentials. This partic-
ularly high activity could be attributed to the presence
of phenolic compounds [31]. The antioxidant activity of
phenolic compounds is mainly due to their redox properties,
which can play an important role in neutralizing free
radicals, quenching singlet and triplet oxygen species, or
decomposing peroxides [32]. Numerous studies have sug-
gested ﬂavonoids, anthraquinones, anthocyanins and tan-
nins[33,34]forantioxidantactivity.Previousphytochemical
investigations on this plant have reported the presence of
ellagic acid derivatives as antioxidant source [22].
These results provide promising baseline information
for the potential use of this plant as well as some of the
fractions in the treatment of GE and oxidative stress. FE and
FF by their high antibacterial activity could be the base of
development of new antibacterial agents with broad spectra.
Their puriﬁcation and pharmacological and toxicity studies
are essential.
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